Synpromics Ltd company
Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.
Founded Date:
2010
Total Funding:
£9.2M
Investor Type:
Company
Employee Number:
1-10
Investment Stage:
N/A
Funding Status:
N/A
Number Of Exists:
Grant
Technology:
Regenerative Medicine
Last Funding Type:
Grant
Investors Number:
3
Industry:
Personalized Medicine
Headquarters:
Edinburgh, Edinburgh, City of, United Kingdom
Estimated Revenue:
$1M to $10M